This report describes the stereotactic technique, hospitalization, and 90-day perioperative safety of bilateral deep brain stimulation (DBS) of the fornix in patients who underwent DBS for the treatment of mild, probable Alzheimer's disease (AD).
The ADvance Trial is a multicenter, 12-month, double-blind, randomized, controlled feasibility study being conducted to evaluate the safety, efficacy, and tolerability of DBS of the fornix in patients with mild, probable AD. Intraoperative and perioperative data were collected prospectively. All patients underwent postoperative MRI. Stereotactic analyses were performed in a blinded fashion by a single surgeon. Adverse events (AEs) were reported to an independent clinical events committee and adjudicated to determine the relationship between the AE and the study procedure.
Between June 6, 2012, and April 28, 2014, a total of 42 patients with mild, probable AD were treated with bilateral fornix DBS (mean age 68.2 ± 7.8 years; range 48.0–79.7 years; 23 men and 19 women). The mean planned target coordinates were x = 5.2 ± 1.0 mm (range 3.0–7.9 mm), y = 9.6 ± 0.9 mm (range 8.0–11.6 mm), z = −7.5 ± 1.2 mm (range −5.4 to −10.0 mm), and the mean postoperative stereotactic radial error on MRI was 1.5 ± 1.0 mm (range 0.2–4.0 mm). The mean length of hospitalization was 1.4 ± 0.8 days. Twenty-six (61.9%) patients experienced 64 AEs related to the study procedure, of which 7 were serious AEs experienced by 5 patients (11.9%). Four (9.5%) patients required return to surgery: 2 patients for explantation due to infection, 1 patient for lead repositioning, and 1 patient for chronic subdural hematoma. No patients experienced neurological deficits as a result of the study, and no deaths were reported.
Accurate targeting of DBS to the fornix without direct injury to it is feasible across surgeons and treatment centers. At 90 days after surgery, bilateral fornix DBS was well tolerated by patients with mild, probable AD.
Clinical trial registration no.: NCT01608061 (clinicaltrials.gov)
Drs. Ponce and Asaad contributed equally to this work.
INCLUDE WHEN CITING Published online December 18, 2015; DOI: 10.3171/2015.6.JNS15716.
Aylward EH, , Schwartz J, , Machlin S, & Pearlson G: Bicaudate ratio as a measure of caudate volume on MR images. AJNR Am J Neuroradiol 12:1217–1222, 1991
Ben-Haim S, , Asaad WF, , Gale JT, & Eskandar EN: Risk factors for hemorrhage during microelectrode-guided deep brain stimulation and the introduction of an improved microelectrode design. Neurosurgery 64:754–763, 2009
Binder DK, , Rau G, & Starr PA: Hemorrhagic complications of microelectrode-guided deep brain stimulation. Stereotact Funct Neurosurg 80:28–31, 2003
Brickman AM, , Honig LS, , Scarmeas N, , Tatarina O, , Sanders L, & Albert MS, et al.: Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer disease. Arch Neurol 65:1202–1208, 2008
Burchiel KJ, , McCartney S, , Lee A, & Raslan AM: Accuracy of deep brain stimulation electrode placement using intraoperative computed tomography without microelectrode recording. J Neurosurg 119:301–306, 2013
Fenoy AJ, & Simpson RK Jr: Risks of common complications in deep brain stimulation surgery: management and avoidance. J Neurosurg 120:132–139, 2014
Fisher R, , Salanova V, , Witt T, , Worth R, , Henry T, & Gross R, et al.: Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia 51:899–908, 2010
Gunduz A, , Morita H, , Rossi PJ, , Allen WL, , Alterman RL, & Bronte-Stewart H, et al.: Proceedings of the Second Annual Deep Brain Stimulation Think Tank: What's in the Pipeline. Int J Neurosci 125:475–485, 2015
Kramer DR, , Halpern CH, , Danish SF, , Jaggi JL, & Baltuch GH: The effect of intraventricular trajectory on brain shift in deep brain stimulation. Stereotact Funct Neurosurg 90:20–24, 2012
Lanctôt KL, , Rajaram RD, & Herrmann N: Therapy for Alzheimer's disease: how effective are current treatments?. Ther Adv Neurol Disorder 2:163–180, 2009
Lang AE, , Houeto JL, , Krack P, , Kubu C, , Lyons KE, & Moro E, et al.: Deep brain stimulation: preoperative issues. Mov Disord 21:Suppl 14 S171–S196, 2006
Laxton AW, , Tang-Wai DF, , McAndrews MP, , Zumsteg D, , Wennberg R, & Keren R, et al.: A phase I trial of deep brain stimulation of memory circuits in Alzheimer's disease. Ann Neurol 68:521–534, 2010
Massano J, & Garrett C: Deep brain stimulation and cognitive decline in Parkinson's disease: a clinical review. Front Neurol 3:66, 2012
Miyagi Y, , Shima F, & Sasaki T: Brain shift: an error factor during implantation of deep brain stimulation electrodes. J Neurosurg 107:989–997, 2007
Rodriguez RL, , Fernandez HH, , Haq I, & Okun MS: Pearls in patient selection for deep brain stimulation. Neurologist 13:253–260, 2007
Rosen WG, , Mohs RC, & Davis KL: A new rating scale for Alzheimer's disease. Am J Psychiatry 141:1356–1364, 1984
Sankar T, , Chakravarty M, , Bescos A, , Lara M, , Obuchi T, & Laxton A, et al.: Deep Brain Stimulation influences brain structure in Alzheimer's Disease. Brain Stimulat 8:645–654, 2015
Sillay KA, , Larson PS, & Starr PA: Deep brain stimulator hardware-related infections: incidence and management in a large series. Neurosurgery 62:360–367, 2008
Smith GS, , Laxton AW, , Tang-Wai DF, , McAndrews MP, , Diaconescu AO, & Workman CI, et al.: Increased cerebral metabolism after 1 year of deep brain stimulation in Alzheimer disease. Arch Neurol 69:1141–1148, 2012
Starr PA, , Turner RS, , Rau G, , Lindsey N, , Heath S, & Volz M, et al.: Microelectrode-guided implantation of deep brain stimulators into the globus pallidus internus for dystonia: techniques, electrode locations, and outcomes. J Neurosurg 104:488–501, 2006
Velasco AL, , Velasco F, , Jiménez F, , Velasco M, , Castro G, & Carrillo-Ruiz JD, et al.: Neuromodulation of the centromedian thalamic nuclei in the treatment of generalized seizures and the improvement of the quality of life in patients with Lennox-Gastaut syndrome. Epilepsia 47:1203–1212, 2006
Weaver FM, , Follett K, , Stern M, , Hur K, , Harris C, & Marks WJ Jr, et al.: Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA 301:63–73, 2009
Zrinzo L, , van Hulzen ALJ, , Gorgulho AA, , Limousin P, , Staal MJ, & De Salles AAF, et al.: Avoiding the ventricle: a simple step to improve accuracy of anatomical targeting during deep brain stimulation. J Neurosurg 110:1283–1290, 2009
Zrinzo L, , Zrinzo LV, , Tisch S, , Limousin PD, , Yousry TA, & Afshar F, et al.: Stereotactic localization of the human pedunculopontine nucleus: atlas-based coordinates and validation of a magnetic resonance imaging protocol for direct localization. Brain 131:1588–1598, 2008
| All Time | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 3965 | 3842 | 225 |
| Full Text Views | 5031 | 44 | 0 |
| PDF Downloads | 1907 | 51 | 0 |
| EPUB Downloads | 0 | 0 | 0 |